Strata Critical Medical, Inc.
SRTA
$4.34
$0.040.93%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 184.71M | 171.48M | 167.58M | 164.79M | 157.91M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 184.71M | 171.48M | 167.58M | 164.79M | 157.91M |
| Cost of Revenue | 142.67M | 133.54M | 128.58M | 127.62M | 124.32M |
| Gross Profit | 42.05M | 37.94M | 39.00M | 37.16M | 33.59M |
| SG&A Expenses | 55.92M | 58.20M | 52.17M | 52.76M | 54.20M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 200.69M | 193.80M | 182.66M | 182.15M | 180.54M |
| Operating Income | -15.97M | -22.32M | -15.08M | -17.37M | -22.63M |
| Income Before Tax | -24.58M | -20.55M | -17.82M | -18.63M | -43.70M |
| Income Tax Expenses | -122.00K | -122.00K | -122.00K | -189.00K | -1.11M |
| Earnings from Continuing Operations | -24.47 | -20.44 | -17.78 | -18.52 | -42.67 |
| Earnings from Discontinued Operations | 67.07M | 3.67M | 3.67M | 3.67M | 3.67M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 40.39M | -18.98M | -26.57M | -27.31M | -51.46M |
| EBIT | -15.97M | -22.32M | -15.08M | -17.37M | -22.63M |
| EBITDA | -10.55M | -16.04M | -9.02M | -11.40M | -16.39M |
| EPS Basic | 0.48 | -0.24 | -0.34 | -0.35 | -0.68 |
| Normalized Basic EPS | -0.09 | -0.14 | -0.08 | -0.09 | -0.12 |
| EPS Diluted | 0.48 | -0.24 | -0.34 | -0.35 | -0.68 |
| Normalized Diluted EPS | -0.09 | -0.14 | -0.08 | -0.09 | -0.12 |
| Average Basic Shares Outstanding | 321.50M | 317.09M | 313.18M | 309.09M | 305.32M |
| Average Diluted Shares Outstanding | 321.50M | 317.09M | 313.18M | 309.09M | 305.32M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |